Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus

CMAJ. 2017 May 23;189(20):E724. doi: 10.1503/cmaj.161455.

¹ Department of Medicine (Goldberg), University of Toronto, Toronto, Ont.; Division of Pharmacoepidemiology and Pharmacoeconomics (Fralick), Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass.; Division of General Internal Medicine (Fralick), Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Ont.
² Department of Medicine (Goldberg), University of Toronto, Toronto, Ont.; Division of Pharmacoepidemiology and Pharmacoeconomics (Fralick), Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass.; Division of General Internal Medicine (Fralick), Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Ont. mif823@mail.harvard.edu.

No abstract available

MeSH terms